NLRP3 Inflammasome Contributes to Host Defense Against Talaromyces
bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
1 NLRP3 inflammasome contributes to host defense against
2 Talaromyces marneffei infection
3
4 Haiyan Ma1, Jasper FW Chan2, Yen Pei Tan2, Lin Kui1, Chi-Ching Tsang2, Steven LC Pei1, Yu-
5 Lung Lau1, Patrick CY Woo2, Pamela P Lee1*
6
7 1.Department of Pediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The
8 University of Hong Kong, Hong Kong SAR, China.
9 2.Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong,
10 Hong Kong SAR, China
11
12 *Correspondence author. E-mail: [email protected]
13
14 Abstract
15 Talaromyces marneffei is an important thermally dimorphic pathogen causing disseminated
16 mycoses in immunocompromised individuals in southeast Asia. Previous study has
17 suggested that NLRP3 inflammasome plays a critical role in antifungal immunity. However,
18 the mechanism underlying the role of NLRP3 inflammasome activation in host defense
19 against T. marneffei remains unclear. We show that T. marneffei yeasts but not conidia
20 induce potent IL-1 response, which is differentially regulated in discrete immune cell types.
21 Dectin-1/Syk signaling pathway mediates pro-IL-1 production, and NLRP3 inflammasome is
22 activated to trigger the processing of pro-IL-1 into IL-1. The activated NLRP3 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
23 inflammasome partially promotes Th1 and Th17 immune responses against T. marneffei
24 yeasts. In vivo, mice with NLRP3 or caspase-1 deficiency exhibit higher mortality rate and
25 fungal load compared to wild-type mice. Herein, our study provides the first evidence that
26 NLRP3 inflammasome contributes to host defense against T. marneffei infection, which may
27 have implications for future antifungal therapeutic designs.
28
29 Introduction
30 Talaromyces marneffei is a dimorphic fungus geographically restricted to Southeast Asia. It
31 causes a form of endemic mycosis that predominantly affects individuals with HIV infection
32 and ranks the third most common opportunistic infection in acquired immunodeficiency
33 syndrome (AIDS), following tuberculosis and cryptococcosis (Sirisanthana & Supparatpinyo,
34 1998; Supparatpinyo et al, 1994; Vanittanakom et al, 2006; Cao et al, 2019). In highly
35 endemic regions such as Chiang Mai in Thailand and Haiphong in Vietnam, T. marneffei is in
36 fact the most common systemic opportunistic fungal infection in AIDS (Vanittanakom et al,
37 2006; Son et al, 2014). Compared with HIV-negative individuals, fungemia, hepatomegaly
38 and splenomegaly occur much more commonly in HIV-positive patients, supporting
39 profound T-lymphopenia as the key predisposing factor for disseminated talaromycosis
40 (Kawila et al, 2013).
41
42 Less commonly, talaromycosis occurs in other immunocompromised conditions such as
43 solid organ or hematopoietic stem cell transplantation, autoimmune diseases or primary
44 immunodeficiency diseases (PID) (Chan et al, 2016; Lee et al, 2012; Lee et al, 2014; Lee &
45 Lau, 2017; Luo et al, 2010; Stathakis et al, 2015). T. marneffei shares some common
46 characteristics with other phylogenetically related dimorphic fungi such as Histoplasma and bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
47 Coccidioides. They exist naturally in the soil environment as conidia which enter the human
48 body via inhalation route, and are converted to the yeast form after being phagocytosed by
49 tissue-resident macrophages. These dimorphic fungal pathogens commonly result in
50 systemic infection when immunity is suppressed, and the uncontrolled proliferation of
51 yeasts in the macrophages eventually lead to dissemination via the reticuloendothelial
52 system. Paracoccidioides brasiliensis and P. lutzii, another dimorphic fungi which is endemic
53 in Latin America, is prevalent in immunocompetent individuals and co-infection with HIV is
54 uncommon, whereas talaromycosis, histoplasmosis and coccidioidomycosis are regarded as
55 AIDS-defining conditions in their respective endemic regions (Limper et al, 2017). They have
56 also been reported in patients with autoantibodies against interferon gamma (anti-IFN),
57 and PID characterized by impaired Th17 immune response such as autosomal dominant (AD)
58 hyper-IgE syndrome caused by loss-of-function STAT3 defect and AD chronic
59 mucocutaneous candidiasis (CMC) caused by gain-of-function STAT1 defect, as well as
60 CD40L deficiency and IFN- receptor deficiency. These acquired defects and inborn errors of
61 immunity provide evidence on the critical role of Th1 and Th17 immune response in host
62 defense against these dimorphic fungi (Lee & Lau, 2017; Lee et al, 2019). However,
63 knowledge about host-pathogen interaction in endemic mycoses is much less
64 comprehensive than other common opportunistic fungal pathogens of worldwide
65 distribution. In particular, little is known about how T. marneffei is recognized by innate
66 immune cells and the ensuing cytokine signaling that triggers adaptive immune response.
67
68 Immune responses against fungal infection are mounted by fungal pathogen-associated
69 molecular patterns (PAMPs) that can be recognized by pathogen recognition receptors (PRRs),
70 including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), NOD-like receptors (NLRs) bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
71 (Erwig & Gow, 2016). CLRs are central for fungal recognition, uptake and induction of innate and
72 adaptive immune responses (Vautier et al, 2012). Dectin-1 specifically recognizes -1,3-glucans
73 in fungal cell wall (Taylor et al, 2007), while Dectin-2 and macrophage inducible C-type lectin
74 (Mincle) recognize -mannan and -mannose, respectively (Vautier et al, 2012). Dectin-1,
75 Dectin-2 and Mincle signal through the Syk-CARD9 pathway which induces NF-kB activation as
76 well as cytokine and chemokine gene expression (Mócsai et al, 2010). NLRP3 is a member of
77 NLRs family, which is able to indirectly sense danger signals, e.g. PAMPs (Schroder & Tschopp,
78 2010). Upon recognition, NLRP3 interacts with adaptor protein ASC that can further recruit pro-
79 caspase-1, leading to the assembly of multiprotein complex known as NLRP3 inflammasome
80 (Latz et al, 2013). Thereafter, pro-caspase-1 can be activated through auto-proteolysis, resulting
81 in the release of caspase-1 p10 and p20 (Schroder & Tschopp, 2010). Active caspase-1 not only
82 processes pro-IL-1 and pro-IL-18 into bioactive IL-1 and IL-18, but also mediates pyroptosis
83 (Man & Kanneganti, 2016). The activation of IL-1 transcription and NLRP3 inflammasome is
84 dependent on the Dectin-1/Syk signaling pathway in human macrophages (Kankkunen et al,
85 2010). The activation of Dectin-1 also triggers the induction of IL-23 through the Syk-CARD9
86 signaling pathway and drives robust Th17 response (LeibundGut-Landmann et al, 2007). The IL-
87 17/IL-23 axis has been shown to promote immunity to C. albicans, Aspergillus and dimorphic
88 fungi such as H. capsulatum (Deepe Jr. & Gibbons, 2009; Chamilos et al, 2010; Wu et al, 2013)
89 and Paracoccidioides brasiliensis (Tristão et al, 2017). In a murine model of disseminated
90 candidiasis, NLRP3 inflammasome exerts antifungal activity through driving protective Th1
91 and Th17 immune responses (van de Veerdonk et al, 2011). NLRP3 inflammasome has also
92 been shown to mediate IL-1 and IL-18 signaling in murine DC and macrophages infected by
93 P. brasiliensis (Tavares et al, 2013; Feriotti et al, 2015; Ketelut-Carneiro et al, 2015), and is bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
94 essential for the induction of protective Th1/Th17 immunity against pulmonary
95 paracoccidioidomycosis (Feriotti et al, 2017; de Castro et al, 2018).
96
97 Previous study showed that IL-1 gene transcription is upregulated in human monocyte-
98 derived DC and macrophages stimulated by T. marneffei (Ngaosuwankul et al, 2008).
99 However, the mechanism of IL-1 induction has not been explored, and whether NLRP3
100 inflammasome plays a role in protective immunity against T. marneffei is unknown. From
101 our earlier work, impaired Th1 and Th17 effector functions emerges as the common
102 pathway in various types of PIDs rendering susceptibility to talaromycosis (Lee et al, 2012;
103 Lee et al, 2014; Lee et al, 2019; Lee & Lau, 2017). In this study, we sought to investigate the
104 role of NLRP3 inflammasome in the induction of Th1 and Th17 immune response to T.
105 marneffei. Our findings show that Dectin-1/Syk signaling pathway mediates pro-IL-1
106 production, and NLRP3 inflammasome is assembled to enhance the processing of pro-IL-1
107 and pro-IL-18 into mature IL-1 and IL-18 in response to T. marneffei yeasts. T. marneffei
108 induces Th1 and Th17 cell differentiation, which is attenuated by caspase-1 inhibition.
109 Furthermore, our in vivo studies show that NLRP3 and caspase-1 confer protection against
110 disseminated T. marneffei infection.
111
112 Results
113 T. marneffei yeasts, but not conidia, induce potent IL-1 response in human PBMCs
114 To dissect the production of cytokines elicited by T. marneffei, freshly isolated human
115 peripheral blood mononuclear cells (PBMCs) were co-cultured with T. marneffei yeasts or
116 conidia at 0.5 multiplicity of infection (MOI) for indicated incubation time points. As shown
117 in Fig 1A, IL-1became detectable at 8 hr, peaked at 18 hr, and remained plateaued bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
118 thereafter till day 5 post infection in the culture supernatant of human PBMCs infected with
119 live T. marneffei yeasts. On the other hand, TNF- production was detectable as early as 4
120 hr, and rapidly peaked at 18 hr, and subsequently showed a slight falling trend up to day 5
121 post infection (Fig 1B). These data demonstrated that T. marneffei yeasts were a potent
122 inducer of IL-1 and TNF-a production. In contrast to T. marneffei yeasts, only minimal levels
123 of IL-1 was detected in PBMCs co-cultured with conidia at 5 days post infection (Fig 1C),
124 whereas TNF- production began to increase steadily after 2 days of incubation (Fig 1D).
125 This suggests that T. marneffei conidia were able to trigger TNF- production in PBMCs but
126 failed to induce IL-1response.
127
128 To examine whether the viability of T. marneffei is a prerequisite for the induction of IL-1
129 in PBMCs, yeasts and conidia were inactivated by heat (100C for 40 min) or 4%
130 paraformaldehyde (PFA) treatment for 10 min. Our results showed that there was no
131 significant difference in IL-1 production in PBMCs infected with live, heat-killed or PFA-
132 treated T. marneffei yeasts (Fig EV1A), indicating that the viability of T. marneffei yeasts was
133 not necessary for the induction of IL-1 response. In contrast, IL-1 production in the
134 PBMCs stimulated with heat-killed conidia was significantly higher compared to live and
135 PFA-treated conidia (Fig EV1B), suggesting that heat treatment might promote the exposure
136 of some pro-inflammatory PAMPs on the conidia cell wall to induce IL-1 response. In
137 addition, both yeast and pseudo-hyphal forms of C. albicans were capable of inducing IL-1
138 production in human PBMCs, and no differential IL-1 response was observed for heat- and
139 PFA-treated C. albicans (Fig EV1C and D).
140 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
141 We further evaluated the production of other pro-inflammatory cytokines in T. marneffei
142 yeasts-infected human PBMCs. As shown in Fig 1E-J, IFN- and IL-17A could be detected only
143 after 3 days of co-culture, whereas IL-6, MCP-1, IL-8 and IL-18 were detectable as early as 18
144 hr. Specifically, IFN-production reached its maximum at 3 days and slightly reduced at 5
145 days, while IL-17A production greatly increased from 3 days to 5 days of co-culture (Fig 1E
146 and F). IL-6 and MCP-1 production peaked at 18 hr and remained at similar levels at 3 days
147 and 5 days of co-culture (Fig 1G and H). IL-8 and IL-18 production was maximal at 18 hr and
148 showed a downward trend thereafter (Fig 1I and J). These results suggested that T.
149 marneffei yeasts sequentially activated innate and adaptive immune responses.
150
151 Differential requirement for IL-1 response to T. marneffei yeasts in various human
152 immune cell types
153 It has been suggested that IL-1 production can be mediated by inflammasome activation
154 which requires two signals: the triggering of pro-IL-1 production (signal 1) and the
155 processing of pro-IL-1 into mature IL-1 (Signal 2) (Latz et al, 2013). To investigate whether
156 there was any differential requirement for IL-1 response to yeasts in different cell types,
157 human PBMCs, monocytes, monocytes-derived macrophages and monocytes-derived DCs
158 were primed with or without lipopolysaccharide (LPS) prior to T. marneffei yeasts
159 stimulation. As shown in Fig 2A and B, T. marneffei yeasts alone were able to induce
160 abundant IL-1 production in PBMCs and monocytes, indicating that yeasts provided ‘signal
161 1’ and ‘signal 2’ for inflammasome activation in these cell types. In contrast, LPS priming
162 was required for IL-1 response to T. marneffei yeasts in macrophages and DCs (Fig 2C and
163 D), suggesting that T. marneffei yeasts only provided ‘signal 2’, and the pro-IL-1induced by
164 LPS (‘signal 1’) was essential in triggering inflammasome activation in these two cell types. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
165 On the other hand, high level of TNF- could be detected in human PBMCs (Fig 2E),
166 monocytes (Fig 2F) and DCs (Fig 2H), but not in macrophages (Fig 2G), after T. marneffei
167 yeast stimulation.
168
169 Dectin-1/syk signaling mediates IL-1 response to T. marneffei yeasts in human
170 monocytes
171 Dectin-1 recognizes -1,3-glucans in fungal cell wall, which leads to pro-inflammatory
172 immune responses (Hardison & Brown, 2012). To elucidate the involvement of Dectin-1 in
173 the initiation of IL-1 response to T. marneffei yeasts, human CD14+ monocytes were co-
174 cultured with heat-killed T. marneffei yeasts in the presence of anti-human Dectin-1 or TLR2
175 neutralizing antibodies or isotype controls (mouse IgG or human IgA). As shown in Fig 3A,
176 Dectin-1 blockade resulted in a marked reduction of IL-1 in T. marneffei yeasts-stimulated
177 monocytes compared with mouse IgG treatment group. TNF- production was slightly
178 reduced by Dectin-1 blockade, though not significantly different (Fig 3B). These data
179 suggested that Dectin-1 mediated the production of IL-1 and TNF- in response to T.
180 marneffei yeasts in human monocytes. Conversely, blockade of TLR2 resulted in significantly
181 elevated IL-1 secretion and had no effect on TNF- production in response to yeasts (Fig
182 3C and D), suggesting that TLR2 negatively regulated IL-1 production in the context of T.
183 marneffei stimulation.
184
185 To study the role of Dectin-1/Syk signaling pathway in the induction of IL-1 response to T.
186 marneffei yeasts, we measured Syk phosphorylation in T. marneffei stimulated human
187 CD14+ monocytes by flow cytometry. As expected, T. marneffei yeasts induced Syk
188 phosphorylation compared to the unstimulated cells (Fig 3E). Pre-treatment of CD14+ bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
189 monocytes with R406 (Syk inhibitor) prior to T. marneffei yeasts stimulation resulted in
190 significantly reduced expression of pro-IL-1 in cell lysates (Fig. 3F) as well as IL-1 in culture
191 supernatant (Fig 3G), in a dose-dependent manner. A similar trend of dose-dependent
192 inhibition of TNF- production in monocytes co-cultured with T. marneffei yeasts was also
193 observed (Fig 3H). Collectively, our data suggested that Syk, the molecule that acts
194 downstream to Dectin-1 in the initiation of antifungal immunity (Drummond et al, 2011),
195 played an important role in eliciting IL-1 response to T. marneffei yeasts in human
196 monocytes.
197
198 To verify our hypothesis that caspase-1 activation mediates IL- and IL-18 release in human
199 monocytes infected with T. marneffei yeasts, we pre-treated human CD14+ monocytes with
200 caspase-1 inhibitor (Z-YVAD, 10µM and 20µM) prior to co-culture with heat-killed T.
201 marneffei yeasts. IL-1 and IL-18 secretion was significantly attenuated in Z-YVAD-treated
202 monocytes (Fig 3I and J), whereas inhibition of caspase-1 activity had no obvious effect on
203 TNF-production (Fig 3K), demonstrating that caspase-1 activation contributed to IL-1 and
204 IL-18 release in response to T. marneffei.
205
206 T. marneffei yeasts trigger IL-1 production via the NLRP3 inflammasome
207 To delineate whether IL-1release induced by T. marneffei yeasts was mediated by NLRP3
208 inflammasome, murine bone marrow-derived DCs (BMDCs) from WT, Nlrp3-/-, Casp1-/- mice
209 were co-cultured with heat-killed yeasts, and then NLRP3, caspase-1 p20 and p45
210 expression were analyzed by immunoblots. As shown in Fig 4A, we found that NLRP3
211 expression was obviously upregulated by yeasts in BMDCs from WT and Casp-1-/- mice.
212 Moreover, pro-caspase-1 (p45) expression in cell lysates was comparable between bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
213 unstimulated and yeasts-stimulated cells in either WT or Nlrp3-/- mice. Active caspase-1 p20
214 was detectable in the concentrated supernatant of yeasts-stimulated BMDCs from WT mice,
215 but it was absent in the supernatant from cells deficient in NLRP3 or caspase-1, suggesting
216 that caspase-1 activation is dependent on NLRP3. LPS plus nigericin, which are considered as
217 the activators of classical NLRP3 inflammasome, could activate caspase-1 since active
218 caspase-1 p20 was observed in both cell lysates and supernatant of WT BMDCs.
219
220 To determine whether T. marneffei yeasts could induce ASC specks to mediate IL-1
221 processing, BMDCs from WT and Nlrp3-/- mice were co-cultured with yeasts, and the
222 formation of ASC pyroptosomes (“specks”) was examined. Confocal microscopy revealed
223 that ASC pyroptosomes, appearing as a single cytoplasmic speck, was present in WT cells
224 but not in Nlrp3-/- cells stimulated with T. marneffei yeasts or LPS plus nigericin (Fig 4B). We
225 also quantified the percentage of cells containing ASC specks and observed that around 8%
226 of WT cells formed ASC specks while it was undetectable in Nlrp3-/- cells after T. marneffei
227 yeasts stimulation (Fig 4C). Similarly, LPS plus nigericin could induce about 29% of WT cells
228 containing ASC specks (Fig 4C). Our results indicated that T. marneffei yeasts induced ASC
229 speck formation, which was dependent on NLRP3, to induce IL-1 processing.
230
231 Next, to further test the hypothesis that IL-1 response to T. marneffei yeasts was
232 dependent on NLRP3 inflammasome, BMDCs from WT, Casp-1-/-, and Nlrp3-/- mice were co-
233 cultured with heat-killed T. marneffei yeasts, and IL-1 and TNF- in the supernatant were
234 examined. As shown in Fig 4D, LPS induced a small amount of IL-1 in these BMDCs,
235 whereas there was remarkably lower IL-1in Casp-1-/- and Nlrp3-/- BMDCs than WT cells
236 after stimulation with LPS plus nigericin. More importantly, we observed that BMDCs from bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
237 Casp-1-/- and Nlrp3-/- mice had significantly impaired IL-1 response to T. marneffei yeasts
238 when compared with WT mice (Fig 4D). Furthermore, an intriguing observation was that IL-
239 1 production in BMDCs from Nlrp3-/- mice was slightly lower than those from Casp-1-/-mice
240 after T. marneffei yeasts stimulation with or without LPS priming (Fig 4D), indicating that IL-
241 1 response to T. marneffei yeasts was more dependent on NLRP3 than caspase-1. In
242 contrast to IL-1 production, BMDCs from WT, Casp-1-/-, and Nlrp3-/- mice produced
243 comparable levels of TNF- when co-cultured with T. marneffei yeasts (Fig 4E). Collectively,
244 these results corroborated that NLRP3 and caspase-1 were required for IL-1 response to T.
245 marneffei yeasts in murine BMDCs.
246
247 T. marneffei yeasts elicit differential Th1 and Th17 immune responses in human CD14+
248 monocytes and monocytes-derived DCs.
249 We have observed that T. marneffei yeasts triggered IFN- and IL-17A production in human
250 PBMCs (Fig 1E and F). To further validate our hypothesis that T. marneffei yeasts would
251 induce Th1 and Th17 immune responses, isolated human CD4+ T cells were co-cultured with
252 autologous monocytes or monocytes-derived DCs with T. marneffei yeasts or C. albicans for
253 7 and 12 days, and intracellular IFN-and IL-17A production in CD4+ T cells was quantified by
254 flow cytometry. Upon co-culture of CD4+ T cells with T. marneffei yeasts, no IFN-- or IL-17A-
255 producing cells could be detected (Figs 5A-C, and EV2A and B). However, when CD4+ T cells
256 were co-cultured with T. marneffei yeasts for 7 and 12 days in the presence of monocytes,
257 robust IFN- and/or IL-17A production was evident (Figs 5A,B, G, and EV2C and D), while no
258 statistically significant differences were observed for IL-17A-producing cells on day 12 (Fig
259 5B) and IFN-+IL-17A+ -producing cells on day 7 and 12 (Fig 5C) after stimulation with T.
260 marneffei yeasts. These findings suggested that the induction of Th1 and Th17 response by T. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
261 marneffei yeasts required the presence of antigen presenting cells (APCs) such as
262 monocytes. We also found that C. albicans yeasts induced much stronger Th1 and Th17
263 immune responses than T. marneffei in the presence of monocytes (Figs 5A-C, and G, and
264 EV2C and D). Consistent with IFN- and IL-17A production, increased T-bet and RORt, the
265 master transcription factors of respective Th1 and Th17 cells, were observed in CD4+ T cells
266 after co-culture with TM yeasts-primed autologous monocytes for 7 days (Fig EV2G and H).
267 Distinct from CD14+ monocytes, monocytes-derived DCs stimulated with T. marneffei or C.
268 albicans yeasts induced delayed Th1 and Th17 cell differentiation; the remarkable increase
269 in the percentage of IFN- -and/or IL-17A-producing CD4+ T cells could mostly be detected
270 on day 12 when T cells were co-cultured with T. marneffei or C. albicans yeasts in the
271 presence of DCs (Figs 5D-F, and EV2E and F).
272
273 In order to further dissect the difference between monocytes and DCs in promoting the
274 differentiation of CD4+ T cells after fungal stimulation, we next assessed the release of IL-
275 12p70 and IL-23, which are considered to be the key cytokines driving Th1 and Th17 cell
276 differentiation respectively, from human CD14+ monocytes and monocyte-derived DCs. We
277 found that the induction of IL-12p70 and IL-23 by T. marneffei was negligible in monocytes
278 (Fig 5I and J). In contrast, IL-23 was induced by T. marneffei in DCs at a level comparable
279 with C. albicans (Fig 5J).
280
281 Taken together, our data showed that T. marneffei yeasts elicited Th1 and Th17 immune
282 responses in the presence of APCs. CD14+ monocytes exhibited earlier induction of IFN--
283 producing and IL-17A-producing CD4+ T cells than monocyte-derived DCs when co-cultured
284 with T. marneffei or C. albicans. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
285
286 Caspase-1 inhibition attenuates Th1 and Th17 immune response to T. marneffei yeasts
287 To characterize the role of activated NLRP3 inflammasome in the Th1 and Th17 immune
288 responses towards T. marneffei yeasts, human PBMCs were co-cultured with T. marneffei
289 yeasts for 5 days in the presence of caspase-1 inhibitor, Z-YVAD. Blocking of caspase-1
290 activation resulted in significantly reduced IFN- and IL-17A release in response to T.
291 marneffei yeasts (Fig 6A). Next, we determined the percentage of IFN-- and/or IL-17A-
292 producing CD4+ T cells upon co-culture of T. marneffei yeasts-stimulated monocytes and
293 CD4+ T cells in the presence of Z-YVAD. Our results showed that caspase-1 inhibition led to
294 approximately 2-fold reduction in overall IL-17A-producing CD4+ T cells (Fig 6B and D) and
295 IFN-/IL-17A-producing CD4+ T cells (Fig 6B and E), although there was no significant effect
296 on the overall intracellular IFN- production (Fig 6B and C). Our data indicated that NLRP3
297 inflammasome activation partially enhanced T. marneffei yeasts-induced Th1 and Th17
298 immune responses in human immune cells in vitro.
299
300 To clarify the role of caspase-1 and NLRP3 in the induction of Th1 and Th17 response to T.
301 marneffei, we isolated murine splenocytes from wild-type, Casp-1-/-, Nlrp3-/- mice and
302 incubated them with T. marneffei yeasts for 2 days or 6 days, and the supernatant was
303 collected for the quantification of IFN- and IL-17A. As shown in Fig 6F, it was observed that
304 splenocytes from Casp-1-/- and Nlrp3-/- mice had impaired IFN- and IL-17A production
305 compared to WT mice at 2 days post stimulation, while there was no statistically significant
306 effect on IL-17A. On day 6 of incubation, IFN- and IL-17A production by Casp-1-/- and Nlrp3-
307 /- splenocytes was sharply increased and reached a similar level as splenocytes from WT bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
308 mice. Our findings suggested that NLRP3 inflammasome activation promoted early stage of
309 IFN- production in murine splenocytes.
310
311 The NLRP3 inflammasome controls antifungal immunity in vivo
312 Our in vitro study has demonstrated that T. marneffei yeasts activated NLRP3
313 inflammasome that promoted Th1 and Th17 immune responses. To examine the protective
314 role of NLRP3 inflammasome in defense against T. marneffei infection in vivo, WT, Casp-1-/-,
315 Nlrp3-/- mice were infected with 5x105 CFU of T. marneffei yeasts per mouse by intravenous
316 injection and their survival was monitored. As shown in Fig 7A, Casp-1-/- and Nlrp3-/- mice
317 were more susceptible to T. marneffei yeasts infection than WT mice. Of note, Casp-1-/- mice
318 showed more resistance to fungal infection than Nlrp3-/- mice. These observations
319 suggested that NLRP3 and caspase-1 conferred host protection against T. marneffei
320 infection, in particular, NLRP3 played a more protective role than caspase-1. To further
321 investigate the factors resulting in the differential survival rates among WT, Casp-1-/-, Nlrp3-
322 /- mice, murine spleens and livers were collected at 7 and 14 days post infection (dpi) for
323 fungal load detection. There was comparable fungal load in spleens from WT, Casp-1-/-,
324 Nlrp3-/- mice at 7 dpi (Fig 7B). Nevertheless, significantly elevated fungal load was observed
325 in spleens from Nlrp3-/- mice when compared to WT mice at 14 dpi (Fig 7B). Similarly, liver
326 specimen from Nlrp3-/- mice exhibited the highest fungal load, followed by Casp-1-/- mice,
327 and WT mice showed the least fungal load in livers at 7 and 14 dpi (Fig 7C). It was worth
328 noting that the fungal load in spleens and livers from WT mice at 14 dpi was similar to that
329 at 7 dpi, whereas the fungal load in these organs from Nlrp3-/- mice at 14 dpi was
330 significantly higher than that 7 dpi (Fig 7B and C), indicating that NLRP3 inflammasome
331 played a pivotal role in the control of T. marneffei proliferation. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
332
333 Histological studies of liver sections from WT, Casp-1-/- and Nlrp3-/- mice at 7 dpi showed a
334 great number of granulomas (Fig 7D, upper panel). By day 14, granulomas were
335 considerably enlarged and almost replaced the liver parenchyma in Casp-1-/- and Nlrp3-/-
336 mice when compared to those at 7 dpi, but liver sections from WT mice exhibited a smaller
337 number of granulomas (Fig 7D, lower panel). HE staining of livers revealed that WT mice had
338 relatively fewer cytoplasmic fungal yeasts within macrophages in the central granulomas
339 than Casp-1-/- and Nlrp3-/- mice (Fig 7D, insets of lower panel). Tissue necrosis was not
340 observed in all three strains of mice. GMS staining further verified that fungal yeasts were
341 present in the center of granulomas (Fig 7E). Slightly fewer yeasts were observed in WT
342 mice than Nlrp3-/- and Casp-1-/- mice at 7 dpi (Fig 7E, upper panel). Importantly, massive
343 number of T. marneffei yeasts were seen in the granulomas of Casp-1-/- and Nlrp3 -/- livers,
344 while T. marneffei yeasts were sparse in the granulomas of WT mice at 14 dpi (Fig 7E, lower
345 panel). Spleen sections of Nlrp3-/- mice showed a more severe loss of follicular structure in
346 the white pulp than WT and Casp-1-/- mice at 7 dpi (Fig EV3A, upper panel). No granulomas
347 were observed in the spleens (Fig EV 3A). We failed to detect T. marneffei in the spleens at 7
348 dpi, but scattered fungal yeasts could be seen in the spleens of WT, Nlrp3-/- and Casp-1-/-
349 mice at 14 dpi by GMS staining (Fig EV3B). In conclusion, these histopathological
350 examinations further demonstrated that NLRP3 inflammasome was essential for host
351 defense against T. marneffei infection in vivo.
352
353 Discussion
354 T. marneffei is an important form of endemic mycoses causing major morbidity and
355 mortality in patients with HIV infection, as well as those with primary and secondary bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
356 immunodeficiencies. However, innate immune recognition of T. marneffei and the induction
357 of adaptive immunity, is largely unknown. For the first time, our study characterizes Syk-
358 and caspase-1 mediated IL-1 response towards T. marneffei in human myeloid cells, and
359 the role of caspase-1 in the induction of Th1 and Th17 response in human lymphocytes.
360 Importantly, our murine model of disseminated talaromycosis demonstrates increased
361 fungal load in the liver and spleen of Casp-1-/- and Nlrp3-/- mice, and correlates with reduced
362 survival.
363
364 Human T. marneffei infection is initiated by inhalation of conidia existing in the environment.
365 After phagocytosis by pulmonary alveolar macrophages, T. marneffei conidia undergo
366 morphological switch and germinate into the pathogenic yeast cells, which readily disseminate
367 throughout the body causing systemic infection. Our findings reveal differential cytokine
368 response towards T. marneffei conidia and yeasts in human PBMCs (Fig 1A-D). These
369 interesting findings indicate that conidia are less immunological than yeasts, as shown by
370 negligible IL-1 and TNF- production in PBMCs during the first 24-48 hours of co-culture.
371 The delayed rise in TNF-, and IL-1 to a lesser extent, after 3 days of co-culture probably
372 represents the switch of conidia to yeast form in vitro, suggesting that the transformation of
373 conidia into yeasts would be required for IL-1 response. The change in cell wall composition
374 and architecture during different life stages of fungi can lead to differential exposure of PAMPs
375 in the inner cell wall, causing varying degree of PRR activation which determines the level of
376 pathogenicity (Cheng et al, 2011).
377
378 Our work demonstrates that IL-1 response to T. marneffei yeasts is partially mediated by
379 Dectin-1/Syk signaling pathway. Blockade of Dectin-1 with neutralizing antibodies impairs bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
380 the production of IL-1 and TNF- to a lesser extent, in response to T. marneffei yeasts in
381 human CD14+ monocytes. This suggests that Dectin-1 plays a role in initiating downstream
382 signaling that leads to pro-IL-1 and TNF- production, which has been demonstrated in
383 other fungal pathogens such as C. albicans and H. capsulatum (Chang et al, 2017; Hise et al,
384 2009). We further show that T. marneffei yeasts are capable of inducing Syk kinase
385 phosphorylation, and blockade of Syk kinase significantly inhibits both pro-IL-1 and IL-1 as
386 well as TNF- in a dose-dependent fashion (Fig 3F-H). Acquired immunity to other
387 dimorphic fungi such as Blastomyces dermatitidis, Histoplasma capsulatum and Coccidioides
388 posadasii infection variably depends on innate sensing by Dectin-1, Dectin-2 and Mincle
389 (Wang et al, 2014), and the role of these CTL receptors in cytokine response against T.
390 marneffei will require further studies.
391
392 TLR2 heterodimerizes with either TLR1 or TLR6 and recognizes triacylated and diacylated
393 lipoprotein. TLR2 and dectin-1 physically associate with one another and synergize to
394 augment anti-fungal response by modulating cytokine production (Dennehy et al, 2009;
395 Gantner et al, 2003; Hise et al, 2009). Our results show that blockade of TLR2 leads to
396 increased IL-1 production but has no impact on TNF- production in T. marneffei yeasts-
397 stimulated human monocytes (Fig 3C and D), suggesting that TLR2 ligation might exert a
398 negative effect on IL-1-mediated immune response against T. marneffei. TLR2-deficient
399 mice infected with P. brasiliensis have preferential activation of Th17 response and lower
400 fungal load, while Treg expansion is diminished and aggravates lung inflammation (Loures et
401 al, 2010). A similar role of TLR2 was also observed in a murine model of disseminated
402 candidiasis, where TLR2 exerts anti-inflammatory effect by promoting IL-10 production and
403 Treg cell proliferation (Netea et al, 2004). bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
404
405 It was previously shown that IL-12p40 production is induced by T. marneffei in murine
406 BMDCs, and is mediated by Dectin-1, TLR2 and MyD88 (Nakamura et al, 2008). Our data
407 showed that IL-12p70 could not be induced by T. marneffei yeasts in human CD14+
408 monocytes and monocyte-derived DCs. This confirms the previous published finding that T.
409 marneffei yeasts do not upregulate IL-12 expression in human monocyte-derived DCs and
410 monocyte-derived macrophages (Ngaosuwankul et al, 2008). Furthermore, our findings
411 provide strong evidence that human Th17 cells are expanded when co-cultured with T.
412 marneffei-stimulated monocytes or monocyte-derived DCs, in contrast to the findings from
413 a recent study showing that murine BMDCs are unable to induce, or actually lower, the
414 percentage of Th17 cells upon co-culture with T. marneffei (Tang et al, 2020). These
415 observations point to the possible difference in Th1 and Th17 immune response towards T.
416 marneffei in human vs murine hosts.
417
418 We demonstrate that IFN- and IL-17A-producing human CD4+ T cells are induced by T.
419 marneffei-primed human CD14+ monocytes (Fig 5A and B and G), albeit less strong as C.
420 albicans-primed monocytes. IL-12 is an important cytokine which induces the differentiation
421 of naïve CD4+ T cell into IFN- secreting Th1 cells, whereas differentiation of naïve CD4+ T-
422 cells to Th17 cells is a result of the combined activity of IL-23 and IL-1 (Goncalves et al,
423 2017; Zhou et al, 2009). As neither IL-12 nor IL-23 could be detectable upon co-culture of T.
424 marneffei-stimulated human CD14+ monocytes (Fig 5I and J), this suggests that cytokines
425 other than IL-12 and IL-23 might be secreted by human monocytes for the differentiation of
426 Th1 and Th17 cells in response to T. marneffei infection. For example, it was found that IL-6
427 contributes to IFN- expression in lung tissues in a murine model of systemic P. brasiliensis bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
428 infection (Tristão et al, 2017). Alternatively, Th17 cells against T. marneffei could originate
429 from memory T cells that are cross-reactive to C. albicans instead of being differentiated de
430 novo, since Th17 cells cross-reactive to C. albicans have been demonstrated to contribute to
431 Th17 response towards A. fumigatus (Bacher et al, 2019).
432
433 On the other hand, IL-23 could be induced by T. marneffei yeasts in monocyte-derived DCs,
434 but not IL-12 (Fig 5J). The preferential induction of IL-23 over IL-12 response in DCs is
435 possibly related to dectin-1-mediated signaling, as previously shown in H. capsulatum
436 (Chamilos et al, 2010). Furthermore, IL-23 is induced by T. marneffei in human DCs at a level
437 comparable to C. albicans, and correlates with a similar percentage of both IFN- and IL-
438 17A-producing CD4+ T-cells upon co-culture with the two fungal pathogens. IL-12 and IL-23
439 are thought to promote mutually exclusive CD4+ Th1 and Th17 cell fates (Teng et al, 2015),
440 However, recent investigations on human monogenic IL12R2 and IL-23R deficiency, which
441 result in defective responses to IL-12 or IL-23 respectively, show that the isolated absence of
442 IL-12 or IL-23 could in part be compensated by its counterpart for the production of IFN-,
443 conferring protection against intracellular pathogen such as mycobacteria (Martínez-
444 Barricate et al, 2018). In the absence of IL-12, IL-17 is the requisite for the protective effect
445 induced by IL-23 in pulmonary histoplasmosis (Deepe Jr. & Gibbons, 2009). This might
446 explain how loss-of-function mutation in STAT3, which encodes the transcription factor
447 activated by IL-23, leads to increased susceptibility to dimorphic fungi such as T. marneffei,
448 C. immitis and H. capsulatum in AD hyper-IgE syndrome (Lee & Lau, 2017).
449
450 IL-1 is essential for Th17 differentiation in human and mice (Acosta-Rodriguez et al, 2007;
451 Chung et al, 2009). IL-1 synergizes with IL-23 in controlling the expression of RORt and IL- bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
452 23 receptor to sustain IL-17 production by effector Th17 cells (Chung et al, 2009). Another
453 report also indicates that NLRP3 inflammasome-derived IL-18 and IL-1 drive protective Th1
454 and Th17 immune responses in disseminated candidiasis (van de Veerdonk et al, 2011).
455 Consistently, treatment of human PBMCs with caspase-1 inhibitor, which suppressed the
456 production of IL-1 and IL-18 production in human monocytes (Fig 3I and J), significantly
457 impaired the secretion of IFN- and IL-17A, and the differentiation of IL-17A-producing-T
458 cells (Fig 6C-E). These findings highlight the important role of caspase-1 in bridging the
459 innate and adaptive immune response, particularly Th17 response towards T. marneffei
460 infection in human cells.
461
462 Furthermore, in line with the role of inflammasome activation in host defense against C.
463 albicans (Hise et al, 2009) and A. fumigatus (Karki et al, 2015), our study defined the critical
464 role of NLRP3 and caspase-1 in the induction of IL-1 response to T. marneffei. In WT
465 BMDCs, T. marneffei yeasts strongly upregulated the expression of NLRP3, cleavage of pro-
466 caspase-1 to caspase-1 p20, and the formation of ASC pyroptosomes (Fig 4A and C). Using
467 the murine model of systemic T. marneffei infection, we found that Nlrp3-/- and Casp-1-/-
468 mice had higher mortality rate. Of note, the fungal load in the spleen and liver of WT mice
469 were comparable on 7 dpi and 14 dpi, while an increase in fungal load became obvious on
470 14 dpi in Casp-1-/- and Nlrp3-/- mice, particularly the latter (Fig 7A-C). This suggests that
471 NLRP3/Caspase-1 signaling is crucial in controlling fungal proliferation in vivo.
472
473 An intriguing observation is that the significantly lower survival rate of Nlrp3-/- mice
474 correlated with higher fungal load, particularly in the liver at 14 dpi, compared with Casp-1-/-
475 mice (Fig 7A-C). These in vivo data correlate well with IL-1 response to T. marneffei in bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
476 murine BMDCs in vitro, reinforcing the critical role of IL-1 in protective immunity against T.
477 marneffei. The residual IL-1 response to T. marneffei in BMDCs from Casp-1-/- and Nlrp3-/-
478 mice (Fig 4D), and particularly the lower fungal load and better survival in Casp-1-/- mice
479 compared to Nlrp3-/- mice (Fig 7A-C), suggests possible contributions from alternate
480 signaling pathways. For example, the engagement of Dectin-1 by P. brasiliensis activates
481 caspase-8 which drives the transcriptional priming and post-translational processing of pro-
482 IL-1. Interestingly, the canonical caspase-1 inflammasome pathway normally restricts the
483 noncanonical caspase-8 inflammasome activation, therefore in the context of caspase-1/11
484 deficiency, the lack of inhibition from caspase-1 enables caspase-8-dependent IL-1
485 processing (Ketelut-Carneiro et al, 2018). A recent study show that IL-1 release via
486 caspase-11-mediated pyroptosis induced by P. brasiliensis reprograms Th17 lymphocytes to
487 produce high levels of IL-17 and enhances effector mechanisms by innate cells (Ketelut-
488 Carneiro et al, 2019). Further studies are required to investigate alternative molecular
489 pathways in the induction of inflammasome activation against T. marneffei infection.
490
491 DCs from patients with HIV was previously shown to exhibit poor activation of NLRP3
492 inflammasome in response to PAMPs and DAMPs, which could be the consequence of
493 increased basal expression and activation of NLRP3 induced by HIV in chronic infection
494 leading to immune exhaustion (Pontillo et al, 2012), as well as the inhibitory effect on
495 NLRP3 inflammasome activity by type I interferon which is commonly elevated in plasma of
496 HIV-infected patients (Reis et al, 2019; Hardy et al, 2013). In response to LPS stimulation,
497 PBMCs from HIV patients express relatively lower levels of activated caspase-1 (Ahmad et al,
498 2002), and IL-1 production in DCs fails to be upregulated by either LPS (Pontillo et al, 2012)
499 or ATP which classically induces canonical activation of NLRP3 (Reis et al, 2019). It is possible bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
500 that functional defect of NLRP3 could represent an additional contributory factor to
501 increased susceptibility to T. marneffei infection in HIV-positive individuals. Further studies
502 on functional evaluation of NLRP3 and caspase-1 activation in HIV-positive patients infected
503 with T. marneffei will be required.
504
505 This study enhances our understanding of host defense mechanisms against T. marneffei.
506 Knowledge about human immune response towards T. marneffei will have therapeutic
507 implications in managing patients suffering from this fatal infection. Delineation of the roles
508 of various cytokines towards protection against T. marneffei will provide important
509 information to the treatment of patients who have secondary immunodeficiency resulting
510 from the use of biologics for immunological disorders. For example, with the increasingly
511 wide clinical use of IL-1receptor antagonist (e.g. Anakinra, Rilonacept) or neutralization
512 antibodies (Canakinumab) for patients with auto-inflammatory or auto-immune diseases,
513 and therefore clinicians should be alerted to the susceptibility and signs of talaromycosis
514 when treating patients who reside in endemic regions where there is increased risk of
515 environmental exposure to T. marneffei. Finally, the study of functional cellular response
516 towards T. marneffei may provide breakthroughs for the discovery of monogenic immune
517 defects in patients with talaromycosis which is not otherwise explained. It is possible that
518 genetic defects in molecules involved in Dectin-1/Syk signaling pathway, NLRP3
519 inflammasome activation and induction of Th1 and Th17 immune responses might
520 predispose to T. marneffei infection.
521
522 To conclude, in this study, we first demonstrate that T. marneffei yeasts rather than conidia
523 induce IL-1response, which is differentially regulated in distinct cell types. Our findings bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
524 show that Dectin-1/Syk signaling pathway mediates pro-IL-1 production upon fungal
525 stimulation. T. marneffei yeasts also trigger the assembly of NLRP3-ASC-caspase-1
526 inflammasome to facilitate IL-1 maturation. The activated inflammasome partially
527 enhances Th1 and Th17 immune responses against fungal infection. Nlrp3-/- and Casp1-/-
528 mice are more susceptible to T. marneffei yeasts with higher fungal load as compared to WT
529 mice. Collectively, our study highlights the importance of NLRP3 inflammasome in host
530 defense against T. marneffei infection and sheds new light on the interaction between host
531 and fungal cells.
532
533 Materials and Methods
534 Fungi
535 T. marneffei and C. albicans were isolated from patients by the Department of Microbiology,
536 Queen Mary Hospital. T. marneffei conidia were cultured on Sabouraud Dextrose Agar (SDA)
537 plates at 25C for 7 days, and then collected in sterile water by wet cotton swabs, washed 3
538 times and re-suspended in sterile water, and finally filtered through 40µm nylon filters. To
539 prepare T. marneffei yeasts, T. marneffei conidia were cultured on SDA plates at 37C for 10
540 days, and then collected in sterile 0.1% PBST by wet cotton swabs, washed 3 times and re-
541 suspended in RPMI 1640 with shaking for 24 hr at 37C, and finally filtered through 40µm
542 nylon filters. C. albicans were cultured on SDA plates at 30℃ for 48 hr. Then, they were
543 transferred to Sabouraud Dextrose (SD) broth and incubated at 37C with shaking for 16–24
544 hr to obtain the yeast form of C. albicans. Simultaneously, C. albicans were cultured with
545 shaking in enriched media consisting of RPMI+10% fetal bovine serum (FBS) at 37C for 24
546 hr to obtain the pseudo-hyphae form of C. albicans. For fixed fungal preparation, fungi were bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
547 washed in sterile PBS, fixed in 4% paraformaldehyde (PFA) solution for 10 min, and then
548 washed three times in sterile PBS. For heat-killed fungal preparation, fungi were boiled at
549 100C for 40 min.
550
551 Cell isolation and culture
552 Peripheral blood mononuclear cells (PBMCs) were isolated from the buffy coats of healthy
553 donors according to the principles of the Declaration of Helsinki and were approved by the
554 responsible ethics committee (Institutional Review Boards of the University of Hong
555 Kong/Hospital Authority Hong Kong West Cluster). Human primary CD14+ monocytes and
556 CD4+ T cells were isolated from PBMCs by magnetic labeling with CD14 or CD4 microbeads
557 respectively, followed by positive selection with MACS columns and separators (Miltenyi
558 Biotec). For preparation of monocyte-derived macrophages, PBMCs were cultured in 10cm
559 dish, and medium was changed gently at 2 hr after cell seeding. Cells were left overnight,
560 and adherent cells were treated with cold 5mM EDTA for 10 min, scrapped and cultured in
561 24-well plates for 12 days. During this period, medium was changed on day 7 and day 9 to
562 remove non-adherent cells. Human PBMCs, CD14+monocytes, monocyte-derived
563 macrophages were cultured in RPMI 1640 supplemented with 5% heat-inactivated
564 autologous sera and 1% penicillin/streptomycin. For monocyte-derived dendritic cells (DCs),
565 CD14+ monocytes were cultured for 5 days in RPMI1640 containing 10% FBS, 1%
566 penicillin/streptomycin, human IL-4 (40ng/ml, PeproTech) and GM-CSF (50ng/ml,
567 PeproTech). Non-adherent or loosely adherent cells were collected.
568
569 Murine bone marrow-derived dendritic cells (BMDCs) were prepared as previously
570 described (Helft et al, 2015). Briefly, bone marrow cells were isolated from the femurs and bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
571 tibias of mice. Red blood cells were lysed on ice for 5 min by using 1x RBC Lysis Buffer
572 (BioLegend, 420301). Bone marrow cells (3x106 per well) were cultured in 6-well plates in 3
573 ml of complete medium (RPMI 1640, 1% penicillin/ streptomycin, 10% FBS, 1% Glutamax, 1%
574 sodium pyruvate, and 55M -mercaptoethanol) supplemented with murine GM-CSF (20
575 ng/ml, Peprotech). Half of the medium was removed on day 2 and fresh medium
576 supplemented with murine GM-CSF (40 ng/ml) was added. The culture medium was entirely
577 aspirated on day 3 and replaced by fresh medium containing GM-CSF (20 ng/ml). Non-
578 adherent cells in the culture supernatant and loosely adherent cells were harvested on day
579 6. The experiments that were performed for Western blot analysis of cell culture
580 supernatant were carried out in Opti-MEMTM serum free medium (Gibco). Murine
581 splenocytes were prepared by homogenization of murine spleen, and subsequent lysis of
582 red blood cells, and cultured in the complete medium.
583
584 Cell stimulation
585 PBMCs (4x106/ml) were co-cultured with live, PFA-treated or heat-killed T. marneffei, as
586 well as live, heat-killed or PFA-treated C. albicans yeasts or pseudohyphae at 0.5 multiplicity
587 of infection (MOI) for indicated time points. PBMCs (4x106/ml), CD14+monocytes (2x106/ml),
588 monocyte-derived macrophages (1x106/ml), or monocyte-derived DCs (1x106/ml) were
589 primed with LPS (10ng/ml for PBMCs and monocytes, 100ng/ml for monocyte-derived
590 macrophages and monocyte-derived DCs, Invivogen) for 3 hr and then stimulated with heat-
591 killed T. marneffei yeasts at 0.5 MOI for 18 hr. Human CD14+ monocytes (2x106/ml) were
592 pre-incubated with human anti-Dectin-1 (10g/ml, Invivogen), anti-TLR2 blocking antibodies
593 (10g/ml, Invivogen), or corresponding isotype controls (10g/ml, Invivogen), or different
594 concentrations of R406 (Invivogen), or Z-YVAD(OMe)-FMK (ALX-260-074, Enzo) for 1 hr bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
595 before co-culture with heat-killed T. marneffei yeasts for 18 hr. Murine BMDCs (2x106/ml)
596 were primed with or without LPS (100 ng/ml) for 3 hr, and then co-cultured with heat-killed
597 T. marneffei yeasts at 1 MOI for additional 18 hr. Alternatively, Nigericin (10 M) was added
598 into LPS-primed cells in the last 40 min for positive control. Total CD4+ T cells (1x105/well)
599 were co-cultured for 7 days or 12 days with monocytes (1x105/well)) or monocyte-derived
600 DCs (0.2x105/well) that were pre-pulsed for 3 hr with heat-killed T. marneffei yeasts
601 (1x105/well) or C. albicans yeasts (1x105/well) in 96-well plates. Moreover, murine
602 splenocytes (2x106/ml) were co-cultured with heat-killed T. marneffei yeasts at 1 MOI for 0,
603 2, 6 day(s).
604
605 Cytokine assays
606 Cytokine concentration in culture supernatant was measured by commercial ELISA kits:
607 human IL-1 (ebioscience), human TNF-, IL-18, and IFN-, IL-17A, IL-12p70, and IL-23 (R&D
608 systems), and murine IL-1, TNF-, IFN- and IL-17A (R&D systems) according to
609 manufacturer’s instructions. IL-6, MCP-1, IL-8, IL-18 and IFN- from human PBMCs were
610 measured by LEGENDplex™ Human Inflammation Panel (Biolegend) according to
611 manufacturer’s instructions.
612
613 Western blot
614 Total cell lysates were prepared using sample buffer containing 5% -mercaptoethanol.
615 Protein concentration was determined by bicinchoninic acid (BCA) assay. Concentrated
616 serum free culture supernatant was prepared as previously described (Hornung et al., 2008).
617 Briefly, cell culture supernatant was precipitated by adding an equal volume of methanol
618 and 0.25 volumes of chloroform. It was vigorously vortexed and centrifuged at 20,000 g for bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
619 10 min, and the upper phase was aspirated and discarded, and 500 l methanol was added
620 and centrifuged at 20,000 g for 10 min. Then protein pellet was dried in 55℃ water baths
621 for 5 min. Proteins from cell lysates (20-50 g) or concentrated supernatant were boiled,
622 separated on SDS-PAGE, and transferred onto PVDF membranes (Bio-Rad Laboratories).
623 Membranes were blocked with 5% bovine serum albumin (BSA) in Tris-buffered saline (TBS)
624 with 0.1% Tween 20 for 1 hr at room temperature, incubated overnight at 4℃ with the
625 following primary antibodies diluted 1:1000 in 5% BSA/TBST: anti-pro-IL-1 (#12703, Cell
626 Signaling Technology) and anti-NLRP3 (AG-20B-0014-C100, Adipogen Life Sciences), and
627 anti-mouse caspase-1 (AG-20B-0042-C100, Adipogen Life Sciences), and then incubated for
628 1 hr with goat anti-rabbit and goat anti-mouse secondary antibodies, respectively, at room
629 temperature. Membranes were washed and exposed by adding enhanced
630 chemiluminescence (ECL) in dark room. When necessary, stained membranes were
631 incubated in stripping buffer at 65℃ for 10 min, and washed 3 times with 0.1% TBS-Tween
632 20, and blocked with 5% BSA for 1 hr, and stained with anti--actin rabbit mAb (4970S, Cell
633 Signaling Technology) followed by goat anti-rabbit secondary antibody staining and film
634 exposure.
635
636 Confocal imaging of ASC specks
637 Murine BMDCs (2x106/ml) were seeded on the chamber slides (154941, Nalge Nunc
638 International) and were co-cultured with heat-killed T. marneffei yeasts at 1 MOI for 18 hr,
639 or were stimulated with LPS (100 ng/ml) for 18 hr with addition of Nigericin (10 M) in the
640 last 40 min. BMDCs were fixed with 4% PFA for 20 min and permeabilized with 0.1% Triton-
641 X-100 for 10 min. Cells were washed 3 times and blocked with 5% BSA for 1 hr, followed by
642 incubation with anti-ASC rabbit polyclonal antibody (SC-22514-R, Santa Cruz Biotechnology) bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
643 overnight at 4C. After washing, cells were incubated with AlexaFlour-488 conjugated goat
644 anti-rabbit secondary antibody (Life Technologies) at room temperature for 1 hr.
645 Subsequently, cells were stained with Alexa Fluor 647 phalloidin (ThermoFisher Scientific,
646 A22287) for 30 min at room temperature avoiding light. Finally, slides with cells were
647 mounted with ProLong Gold Antifade Mountant with DAPI (Invitrogen) and analyzed by
648 confocal microscopy (Zeiss LSM 710). For quantification of ASC speck, 40-150 monocytes per
649 field under microscopy with the magnification of 40x objective were manually analyzed, and
650 the ratio of ASC speck positive cells to total cells was calculated. At least 3 fields per sample
651 were counted.
652
653 Flow cytometry
654 To detect Syk phosphorylation, CD14+ monocytes (2x106/ml) were co-cultured with heat-
655 killed T. marneffei yeasts at 0.5 MOI for 18 hr. Cells were fixed with BD Phosflow Fix Buffer I
656 for 10 min at 37℃, followed by permeabilization with BD Phosflow Perm Buffer III for 30
657 min on ice. After washing, cells were stained with PE-conjugated phospho-Syk (Tyk525/526)
658 antibody (#6485, Cell Signaling Technology) for 30 min on ice, and analyzed by flow
659 cytometer (LSR II, BD). For intracellular staining of IFN- and IL-17A, CD4+ T cells were co-
660 cultured with monocytes or monocyte-derived DCs in the presence of T. marneffei yeasts or
661 C. albicans yeasts for 7 days or 12 days. Cells were then stimulated with PMA and ionomycin
662 for 5 hr and Golgi plug (BD Biosicence) was added in the last 4 hr. Subsequently, cells were
663 stained for 30 min at 4C with FITC-conjugated anti-human CD3 antibody (Biolegend),
664 followed by fixation and permeabilization of cells with BD Cytofix/Cytoperm™ (BD
665 Bioscience). After washing, cells were stained with Alexa Fluor® 647-conjugated anti-human bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
666 IFN- antibody (502516, Biolegend) and PE-conjugated anti-human IL-17A antibody (512305,
667 Biolegend) for 30 min at 4℃. Results were analyzed by flow cytometer (LSR II, BD).
668
669 Murine systemic talaromycosis model
670 For in vivo T. marneffei yeasts infection, WT, Nlrp3-/-, Casp1-/- mice were intravenously
671 injected with 100 l of suspension containing 5x105 colony forming units (CFUs) live T.
672 marneffei yeasts in sterile PBS. Mice survival was daily monitored following infection and
673 mice were sacrificed once they showed signs of the humane endpoints. In the second batch
674 of infection experiments, mice were sacrificed, and spleens and livers were harvested at 7
675 or 14 days post infection (dpi) of T. marneffei yeasts. Part of spleen and liver were weighed
676 and homogenized in sterile PBS, and a series of diluted solutions of cell suspensions were
677 plated onto SDA plates. Fungal load was assessed after culturing for 2 days at 25℃. Part of
678 spleen and liver were fixed in 4% paraformaldehyde (PFA) and paraffin slides were prepared
679 for hematoxylin and esosin (HE) staining and Grocott’s methenamine silver (GMS) staining.
680 The stained sections were mounted and observed under microscope for histopathological
681 assessment.
682
683 Data analysis
684 Statistical analysis was carried out using GraphPad Prism v6.0 software. Figure 5G and H
685 were ploted by R software, version 3.6.1. Data were represented as mean ± SEM. Statistical
686 significance was determined by two-tailed Student’s t test, one-way ANOVA or two-way
687 ANOVA with multiple comparison tests, log-rank test or Gehan-Breslow-Wilcoxon test for
688 comparison of survival rate. p<0.05 was considered statistically significant. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
689
690 Acknowledgements
691 We gratefully acknowledge the Laboratory Animal Unit, the Faculty of Core Facility, and the
692 Histopathological Service Center at the Department of Pathology, the University of Hong
693 Kong, for their professional technical supports. This work was supported by the Edward and
694 Yolanda Wong Fund, the RGC General Research Fund (GRF) (HKU project code: 17111814),
695 and the Health and Medical Research Fund (No. HKM-15-M07 [commissioned project]).
696
697 Author contributions
698 HM, JC, YL, PW, PL designed the experiments and analyzed the results. HM, YT, LK, CT, SP
699 performed the experiments. HM and PL wrote and revised the manuscript.
700
701 Conflict of interest
702 The authors declare that they have no conflict of interest.
703
704 References
705 Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and
706 6 but not transforming growth factor-beta are essential for the differentiation of
707 interleukin 17-producing human T helper cells. Nat immunol 8: 942-9
708 Ahmad R, Sindhu ST, Toma E, Morisset R, Ahmad A (2002) Elevated levels of circulating
709 interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral
710 blood mononuclear cells and implications for AIDS pathogenesis. J Virol 76: 12448-56
711 Bacher P, Hohnstein T, Beerbaum E, Rocker M, Blango MG, Kaufmann S, Rohmel J,
712 Eschenhagen P, Grehn C, Seidel K, Rickerts V, Lozza L, Stervbo U, Nienen M, Babel N, bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
713 Milleck J, Assenmacher M, Cornely OA, Ziegler M (2019) Human anti-fungal Th17
714 immunity and pathology rely on cross-reactivity against Candida albicans. Cell 176: 1-16
715 Cao C, Xi L, Chaturvedi V (2019) Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium)
716 marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the
717 Discovery of the Pathogen. Mycopathologia 184: 709-720
718 Chamilos G, Ganguly D, Lande R, Gregorio J, Meller S, Goldman WE, Gilliet M, Kontoyiannis
719 DP (2010) Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates
720 fungal pathogenicity via the induction of T(H)-17 responses. PLoS One 5: e12955
721 Chan JF, Lau SK, Yuen KY, Woo PC (2016) Talaromyces (Penicillium) marneffei infection in
722 non-HIV-infected patients. Emerg Microbes Infect 5: e19
723 Chang TH, Huang JH, Lin HC, Chen WY, Lee YH, Hsu LC, Netea MG, Ting JP, Wu-Hsieh BA
724 (2017) Dectin-2 is a primary receptor for NLRP3 inflammasome activation in dendritic
725 cell response to Histoplasma capsulatum. PLoS Pathog 13: e1006485
726 Cheng SC, van de Veerdonk FL, Lenardon M, Stoffels M, Plantinga T, Smeekens S, Rizzetto L,
727 Mukaremera L, Preechasuth K, Cavalieri D, Kanneganti TD, van der Meer JW, Kullberg BJ,
728 Joosten LA, Gow NA, Netea MG (2011) The dectin-1/inflammasome pathway is
729 responsible for the induction of protective T-helper 17 responses that discriminate
730 between yeasts and hyphae of Candida albicans. J Leukoc Biol 90: 357-66
731 Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten
732 AM, Tian Q, Dong C (2009) Critical regulation of early Th17 cell differentiation by
733 interleukin-1 signaling. Immunity 30: 576-87
734 de Castro LF, Longhi LNA, Paião MR, Justo-Júnior ADS, de Jesus MB, Blotta MHSL, Mamoni
735 RL (2018) NLRP3 inflammasome is involved in the recognition of Paracoccidioides bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
736 brasiliensis by human dendritic cells and in the induction of Th17 cells. J Infect 77: 137-
737 144.
738 Deepe GS Jr, Gibbons RS (2009) Interleukins 17 and 23 influence the host response to
739 Histoplasma capsulatum. J Infect Dis 200: 142-51
740 Dennehy KM, Willment JA, Williams DL, Brown GD (2009) Reciprocal regulation of IL-23 and
741 IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 39:
742 1379-1386
743 Drummond RA, Saijo S, Iwakura Y, Brown GD (2011) The role of Syk/CARD9 couple C-type
744 lectins in antifungal immunity. Eur J Immunol 41: 276-281
745 Erwig LP, Gow NA (2016) Interactions of fungal pathogens with phagocytes. Nat Rev
746 Microbiol 14: 163-76
747 Feriotti C, Bazan SB, Loures FV, Araújo EF, Costa TA, Calich VL (2015) Expression of dectin-1
748 and enhanced activation of NALP3 inflammasome are associated with resistance to
749 paracoccidioidomycosis. Front Microbiol 6: 913
750 Feriotti C, de Araújo EF, Loures FV, da Costa TA, Galdino NAL, Zamboni DS, Calich VLG (2017)
751 NOD-Like Receptor P3 Inflammasome Controls Protective Th1/Th17 Immunity against
752 Pulmonary Paracoccidioidomycosis. Front Immunol 8: 786
753 Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM (2003) Collaborative
754 Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2. J Exp Med
755 197: 1107-1117
756 Goncalves AC, Ferreira LS, Manente FA, de Faria C, Polesi MC, de Andrade CR, Zamboni DS,
757 Carlos IZ (2017) The NLRP3 inflammasome contributes to host protection during
758 Sporothrix schenckii infection. Immunology 151: 154-166 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
759 Hardison SE, Brown GD (2012) C-type lectin receptors orchestrate antifungal immunity. Nat
760 Immunol 13 (9): 817-822
761 Hardy GA, Sieg S, Rodriguez B, Anthony D, Asaad R, Jiang W, Mudd J, Schacker T, Funderburg
762 NT, Pilch-Cooper HA, Debernardo R, Rabin RL, Lederman MM, Harding CV (2013)
763 Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with
764 immune activation and disease markers. PLoS One 8: e56527
765 Helft J, Bottcher J, Chakravarty P, Zelenay S, Huotari J, Schraml BU, Goubau D, Reis e Sousa C
766 (2015) GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of
767 CD11c(+)MHCII(+) Macrophages and Dendritic Cells. Immunity 42: 1197-211
768 Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA (2009) An essential
769 role for the NLRP3 inflammasome in host defense against the human fungal pathogen
770 Candida albicans. Cell host microbe 5: 487-97
771 Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E (2008)
772 Silica crystals and aluminum salts mediate NALP-3 inflammasome activation via
773 phagosomal destabilization. Nat Immunol 9 (8): 847-856
774 Kankkunen P, Teirila L, Rintahaka J, Alenius H, Wolff H, Matikainen S (2010) (1,3)-beta-
775 glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. J.
776 Immunol 184: 6335-42
777 Karki R, Man SM, Malireddi RK, Gurung P, Vogel P, Lamkanfi M, Kanneganti TD (2015)
778 Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host
779 protection against Aspergillus infection. Cell host microbe 17: 357-68
780 Kawila R, Chaiwarith R, Supparatpinyo K (2013) Clinical and laboratory characteristics of
781 penicilliosis marneffei among patients with and without HIV infection in Northern
782 Thailand: a retrospective study. BMC Infect Dis 13: 464 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
783 Ketelut-Carneiro N, Ghosh S, Levitz SM, Fitzgerald KA, da Silva JS (2018) A Dectin-1-Caspase-
784 8 Pathway Licenses Canonical Caspase-1 Inflammasome Activation and Interleukin-1β
785 Release in Response to a Pathogenic Fungus. J Infect Dis 217: 329-339
786 Ketelut-Carneiro N, Souza COS, Benevides L, Gardinassi LG, Silva MC, Tavares LA, Zamboni
787 DS, Silva JS (2019) Caspase-11-dependent IL-1α release boosts Th17 immunity against
788 Paracoccidioides brasiliensis. PLoS Pathog 15: e1007990
789 Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev
790 Immunol 13: 397-411
791 Lee PP, Chan KW, Lee TL, Ho MH, Chen XY, Li CH, Chu KM, Zeng HS, Lau YL (2012)
792 Penicilliosis in children without HIV infection--are they immunodeficient? Clin Infect Dis
793 54: e8-e19
794 Lee PP, Mao H, Yang W, Chan KW, Ho MH, Lee TL, Chan JF, Woo PC, Tu W, Lau YL (2014)
795 Penicillium marneffei infection and impaired IFN-gamma immunity in humans with
796 autosomal-dominant gain-of-phosphorylation STAT1 mutations. J Allergy Clin Immunol
797 133: 894-6 e5
798 Lee PP, Lau YL (2017) Cellular and Molecular Defects Underlying Invasive Fungal Infections-
799 Revelations from Endemic Mycoses. Front Immunol 8: 735
800 Lee PP, Lao-Araya M, Yang J, Chan KW, Ma H, Pei LC, Kui L, Mao H, Yang W, Zhao X,
801 Trakultivakorn M, Lau YL (2019) Application of Flow Cytometry in the Diagnostics
802 Pipeline of Primary Immunodeficiencies Underlying Disseminated Talaromyces
803 marneffei Infection in HIV-Negative Children. Front Immunol 10: 2189
804 LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer
805 E, Tybulewicz V, Brown GD, Ruland J, Reis e Sousa C (2007) Syk- and CARD9-dependent bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
806 coupling of innate immunity to the induction of T helper cells that produce interleukin
807 17. Nat Immunol 8: 630-8
808 Limper AH, Adenis A, Le T, Harrison TS (2017) Fungal infections in HIV/AIDS. Lancet Infect Dis
809 17: e334-e343
810 Loures FV, Pina A, Felonato M, Araújo EF, Leite KR, Calich VL (2010). Toll-like receptor 4
811 signaling leads to severe fungal infection associated with enhanced proinflammatory
812 immunity and impaired expansion of regulatory T cells. Infect Immun 78: 1078-88
813 Luo DQ, Chen MC, Liu JH, Li Z, Li HT (2010) Disseminated Penicillium Marneffei Infection in
814 an SLE Patient: A Case Report and Literature Review. Mycopathologia 171: 191-19
815 Man SM, Kanneganti TD (2016) Converging roles of caspases in inflammasome activation,
816 cell death and innate immunity. Nat Rev Immunol 16: 7-21
817 Martínez-Barricarte R, Markle JG, Ma CS, Deenick EK, Ramírez-Alejo N, Mele F, Latorre D,
818 Mahdaviani SA, Aytekin C, Mansouri D, Bryant VL, Jabot-Hanin F, Deswarte C, Nieto-
819 Patlán A, Surace L, Kerner G, Itan Y, Jovic S, Avery DT, Wong N et al. (2018) Human IFN-γ
820 immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol 3: eaau6759
821 Mócsai A, Ruland J, Tybulewicz VL (2010) The SYK tyrosine kinase: a crucial player in diverse
822 biological functions. Nat Rev Immunol 10: 387-402
823 Nakamura K, Miyazato A, Koguchi Y, Adachi Y, Ohno N, Saijo S, Iwakura Y, Takeda K, Akira S,
824 Fujita J, Ishii K, Kaku M, Kawakami K (2008) Toll-like receptor 2 (TLR2) and dectin-1
825 contribute to the production of IL-12p40 by bone marrow-derived dendritic cells
826 infected with Penicillium marneffei. Microbes Infect 10: 1223-7.
827 Netea MG, Sutmuller R, Hermann C, Van der Graaf CAA, Van der Meer JWM, van Krieken JH,
828 Hartung T, Adema G, Kullberg BJ (2004) Toll-Like Receptor 2 Suppresses Immunity bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
829 against Candida albicans through Induction of IL-10 and Regulatory T Cells. J. Immunol
830 172: 3712-3718
831 Ngaosuwankul P, Pongtanalert P, Engering A, Chaiyaroj SC (2008) Differential gene
832 expression profiles of human monocyte-derived antigen presenting cells in response to
833 Penicillium marneffei: roles of DC-SIGN (CD209) in fungal cell uptake. Asian Pac J
834 Allergy Immunol 26: 151-63.
835 Pontillo A, Silva LT, Oshiro TM, Finazzo C, Crovella S, Duarte AJ (2012) HIV-1 induces NALP3-
836 inflammasome expression and interleukin-1β secretion in dendritic cells from healthy
837 individuals but not from HIV-positive patients. AIDS 26: 11-8
838 Reis EC, Leal VNC, da Silva LT, Dos Reis MML, Argañaraz ER, Oshiro TM, Pontillo A (2019)
839 Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection. Clin
840 Immunol 209: 108266
841 Schroder K, Tschopp J (2010) The inflammasomes. Cell 140: 821-32
842 Sirisanthana T, Supparatpinyo K (1998) Epidemiology and management of penicilliosis in
843 human immunodeficiency virus-infected patients. In 8th International Congress on
844 Infectious Diseases, pp 48-53. Boston, Massachusetts:
845 Son VT, Khue PM, Strobel M (2014) Penicilliosis and AIDS in Haiphong, Vietnam: evolution
846 and predictive factors of death. Med Mal Infect 44: 495-501
847 Stathakis A, Lim KP, Boan P, Lavender M, Wrobel J, Musk M, Heath CH (2015) Penicillium
848 marneffei infection in a lung transplant recipient. Transplant infectious disease : an
849 official journal of the Transplantation Society 17: 429-34
850 Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T (1994) Disseminated
851 Penicillium marneffei infection in Southeast Asia. Lancet 344: 110-13 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
852 Tang Y, Zhang H, Xu H, Zeng W, Qiu Y, Tan C, Tang S, Zhang J (2020) Dendritic Cells Promote
853 Treg Expansion but Not Th17 Generation in Response to Talaromyces marneffei Yeast
854 Cells. Infect Drug Resist 13: 805-813
855 Tavares AH, Magalhaes KG, Almeida RD, Correa R, Burgel PH, Bocca AL (2013) NLRP3
856 inflammasome activation by Paracoccidioides brasiliensis. PLoS Negl Trop Dis 7: e25
857 Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto
858 M, Gordon S, Brown GD (2007) Dectin-1 is required for beta-glucan recognition and
859 control of fungal infection. Nat Immunol 8: 31-8
860 Teng MW, Bowman EP, McElwee JJ, Smyth MJ, Casanova JL, Cooper AM, Cua DJ (2015) IL-12
861 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated
862 inflammatory diseases. Nat Med 21: 719-29
863 Tristão FSM, Rocha FA, Carlos D, Ketelut-Carneiro N, Souza COS, Milanezi CM, Silva JS (2017)
864 Th17-Inducing Cytokines IL-6 and IL-23 Are Crucial for Granuloma Formation during
865 Experimental Paracoccidioidomycosis. Front Immunol 8: 949
866 van de Veerdonk FL, Joosten LA, Shaw PJ, Smeekens SP, Malireddi RK, van der Meer JW,
867 Kullberg BJ, Netea MG, Kanneganti TD (2011) The inflammasome drives protective Th1
868 and Th17 cellular responses in disseminated candidiasis. Eur J Immunol 41: 2260-8
869 Vanittanakom N, Cooper CR, Jr., Fisher MC, Sirisanthana T (2006) Penicillium marneffei
870 infection and recent advances in the epidemiology and molecular biology aspects. Clin
871 Microbiol Rev 19: 95-110
872 Vautier S, MacCallum DM, Brown GD (2012) C-type lectin receptors and cytokines in fungal
873 immunity. Cytokine 58: 89-99 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
874 Wang H, LeBert V, Hung CY, Galles K, Saijo S, Lin X, Cole GT, Klein BS, Wüthrich M (2014) C-
875 type lectin receptors differentially induce th17 cells and vaccine immunity to the
876 endemic mycosis of North America. J Immunol 192: 1107-1119
877 Wu SY, Yu JS, Liu FT, Miaw SC, Wu-Hsieh BA (2013) Galectin-3 negatively regulates dendritic
878 cell production of IL-23/IL-17-axis cytokines in infection by Histoplasma capsulatum. J
879 Immunol 190: 3427-37
880 Zhou L, Chong MM, Littman DR (2009) Plasticity of CD4+ T cell lineage differentiation.
881 Immunity 30: 646-55
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
898 Figure Legends
899 Figure 1. T. marneffei yeasts, but not conidia, induce potent IL-1 response in human
900 PBMCs.
901 A, B. Quantification of IL-1 (A) and TNF- (B) by ELISA in human PBMCs (4x106/ml) infected
902 with live T. marneffei yeasts (0.5 MOI) for indicated time points (n=5, mean ± SEM).
903 C, D. ELISA detection of IL-1 (C) and TNF- (D) in human PBMCs (4x106/ml) infected with
904 live T. marneffei conidia (0.5 MOI) for indicated time points (n=5, mean ± SEM).
905 E. Quantification of IFN- by LEGENDplexTM in human PBMCs (4x106/ml) infected with live
906 T. marneffei yeasts (0.5 MOI) for indicated time points (n=5).
907 F. Quantification of IL-17A by ELISA in human PBMCs (4x106/ml) stimulated with heat-
908 killed T. marneffei yeasts (0.5 MOI) for indicated time points (n=4).
909 G-J. Quantitative analyses of cytokines by LEGENDplexTM in human PBMCs (4x106/ml)
910 infected with live T. marneffei yeasts (0.5 MOI) for indicated time points (n=5).
911 Data information: In (A-D), “h” and “d” denote “hours” and “days”, respectively. In (E-J),
912 each symbol represents one healthy donor.
913
914 Figure 2. Differential requirement for IL-1 response to T. marneffei yeasts in various
915 human immune cell types.
916 A-D. Quantitative ELISA detection of IL-1 in human PBMCs (4x106/ml), CD14+ monocytes
917 (2x106/ml), human monocytes-derived macrophages (1x106/ml), CD14+ monocytes-
918 derived dendritic cells (DCs) (1x106/ml), respectively, after stimulation with heat-killed
919 T. marneffei (TM) yeasts (0.5 MOI) for 18 hr with or without LPS priming.
920 E-H. Quantification of TNF- by ELISA in human PBMCs (4x106/ml), CD14+ monocytes
921 (2x106/ml), human monocytes-derived macrophages (1x106/ml), CD14+ monocytes- bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
922 derived dendritic cells (DCs) (1x106/ml), respectively, after stimulation with heat-killed
923 T. marneffei (TM) yeasts (0.5 MOI) for 18 hr with or without LPS priming.
924 Data information: In (A-H), each symbol represents one healthy donor, and data are
925 analyzed by one-way ANOVA. ns =not significant, ****p<0.0001.
926
927 Figure 3. Dectin-1/syk signaling mediates IL-1 response to T. marneffei yeasts in human
928 monocytes.
929 A, B. Quantification of IL-1 and TNF- by ELISA in human CD14+ monocytes (2x106/ml)
930 stimulated with heat-killed T. marneffei (TM) yeasts (0.5 MOI) for 18 hr in the presence
931 of anti-hDectin-1 blocking antibodies or mouse IgG (mIgG) (10 g/ml).
932 C, D. Quantification of IL-1 and TNF- by ELISA in human CD14+ monocytes (2x106/ml)
933 stimulated with heat-killed T. marneffei (TM) yeasts (0.5 MOI) for 18 hr in the presence
934 of anti-hTLR2 blocking antibodies or human IgA (hIgA) (10 g/ml).
935 E. Detection of median fluorescence intensity (MFI) of phospho-Syk by flow cytometry in
936 human CD14+ monocytes (2x106/ml) stimulated with heat-killed T. marneffei (TM)
937 yeasts (0.5 MOI) for 18 hr (n=3, mean ± SEM).
938 F. A representative immunoblot of pro-IL- of cell lysates in human CD14+ monocytes
939 (2x106/ml) stimulated with heat-killed T. marneffei (TM) yeasts (0.5 MOI) for 18 hr in
940 the absence or presence of Syk inhibitor, R406 (n=3).
941 G, H. ELISA quantification of IL-1 and TNF- in the culture supernatant of human CD14+
942 monocytes (2x106/ml) stimulated with heat-killed T. marneffei (TM) yeasts (0.5 MOI)
943 for 18 hr in the absence or presence of Syk inhibitor, R406. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
944 I-K. Quantification of IL-1, IL-18 and TNF-by ELISA in the culture supernatant of human
945 CD14+ monocytes (2x106/ml) stimulated with heat-killed T. marneffei yeasts (0.5 MOI)
946 for 18 hr in the absence or presence of Z-YVAD (caspase-1 inhibitor).
947 Data information: Data are analyzed by paired two-tailed t test (A-E) or by one-way ANOVA
948 (G-K). Each symbol represents one healthy donor. ns =not significant, *p<0.05, **p<0.01,
949 ***p<0.001, ****p<0.0001.
950
951 Figure 4. T. marneffei yeasts trigger IL-1 production via the NLRP3 inflammasome.
952 A. Representative immunoblots of NLRP3, caspase-1 p45 and p20 from cell lysates and
953 caspase-1 p20 from concentrated cell supernatant in WT, Nlrp3-/- and Casp-1-/- murine
954 BMDCs stimulated with heat-killed T. marneffei (TM) yeasts (1 MOI) for 18 hr, or LPS
955 plus nigericin as a positive control (n=3).
956 B, C. Representative confocal micrographs (B) and the percentages (C) of ASC specks
957 formation in WT, Nlrp3-/- murine BMDCs (2x106/ml) stimulated with heat-killed T.
958 marneffei (TM) yeasts (1 MOI) for 18 hr, or LPS plus nigericin as a positive control.
959 D, E. Quantitative detection of IL-1 and TNF- by ELISA in the cell supernatant of WT, Casp-
960 1-/- and Nlrp3-/- murine BMDCs (2x106/ml) stimulated with heat-killed T. marneffei (TM)
961 yeasts (1 MOI) for 18 hr with or without LPS priming, or LPS plus nigericin as a positive
962 control.
963 Data information: In (C), the percentages of ASC speck positive cells are quantified and
964 depicted as mean ± SEM of n=3 mice for each group, and “ND” denotes “not detectable”. In
965 (D, E), data represent mean±SEM of n=4 mice, and data are analyzed by two-way ANOVA.
966 *p<0.05, **p<0.01, ****p<0.0001.
967 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
968 Figure 5. T. marneffei yeasts elicit differential Th1 and Th17 immune responses in human
969 CD14+ monocytes and monocytes-derived DCs.
970 A-C. Analyses of IFN- and/or IL-17A producing CD4 T cells by flow cytometry in human CD4+
971 T cells (1x105/well) co-cultured with heat-killed T. marneffei- or C. albicans-stimulated
972 autologous CD14+ monocytes (1x105/well) for 7 days and 12 days.
973 D-F. Analyses of IFN- and/or IL-17A producing CD4 T cells by flow cytometry in human CD4+
974 T cells (1x105/well) co-cultured with heat-killed T. marneffei- or C. albicans-stimulated
975 autologous monocytes-derived DCs (0.2x105/well) for 7 days and 12 days.
976 G. Scatter plot of overall IFN--producing CD4 T cells (y axis) and overall IL-17A-producing
977 CD4 T cells (x axis) in (A and B).
978 H. Scatter plot of overall IFN--producing CD4 T cells (y axis) and overall IL-17A-producing
979 CD4 T cells (x axis) in (D and E).
980 I. Quantitative ELISA analysis of IL-12p70 in the supernatant of human CD14+ monocytes
981 (Monocytes) (2x106/ml) and monocytes-derived DCs (MDDCs) (1x106/ml) stimulated
982 with T. marneffei yeasts or C. albican yeasts for 18 hr.
983 J. Quantitative ELISA analysis of IL-23 in the supernatant of human CD14+ monocytes
984 (Monocytes) (2x106/ml) and monocytes-derived DCs (MDDCs) (1x106/ml) stimulated
985 with T. marneffei yeasts or C. albican yeasts for 18 hr.
986 Data information: In (A-H), data are given as the percentage of total gated CD3+ cells. In (A-F,
987 and I-J), data are analyzed by two-way ANOVA and depicted as means ± SEM. ns =not
988 significant, *p<0.05, **p<0.01, p<0.0001. Each symbol represents one healthy donor in all
989 the data.
990 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
991 Figure 6. Caspase-1 inhibition attenuates Th1 and Th17 immune responses to T. marneffei
992 yeasts.
993 A. Quantification of IFN- and IL-17A by ELISA in the supernatant of human PBMCs
994 (4x106/ml) stimulated with heat-killed T. marneffei (TM) yeasts (0.5 MOI) in the
995 absence or presence of caspase-1 inhibitor, Z-YVAD (20M), for 5 days.
996 B. Representative plots of intracellular IFN- and/or IL-17A in the CD4+ T cells (1x105/well)
997 co-cultured with heat-killed T. marneffei (TM) yeasts-stimulated autologous CD14+
998 monocytes (1x105/well) in the absence or presence of Z-YVAD (20M) for 7 days.
999 C-E. Statistical analyses of overall IFN--producing cells (C) and overall IL-17A-producing cells
1000 (D) and IFN-+IL-17A+ -producing cells (E) in co-cultured CD4+ T cells and T. marneffei-
1001 primed autologous CD14+ monocytes in the absence or presence of Z-YVAD for 7 days
1002 as described in (B).
1003 F. Detection of murine IFN- and IL-17A by ELISA in the supernatant of WT, Casp-1-/- and
1004 Nlrp3-/- murine splenocytes (2x106/ml) stimulated with heat-killed T. marneffei yeasts
1005 (1 MOI) for indicated time points.
1006 Data information: In (A) and (C-E), each symbol represents one healthy donor, and data are
1007 analyzed by paired two-tailed Student’s t tests. In (F), data are depicted as mean ± SEM of
1008 n=4 mice and are analyzed by two-way ANOVA. ns=not significant, *p<0.05, ***p<0.001,
1009 ****p<0.0001.
1010
1011 Figure 7. The NLRP3 inflammasome controls antifungal immunity in vivo
1012 A. Survival plot of WT, Casp-1-/- and Nlrp3-/- mice intravenously injected with live T.
1013 marneffei yeasts (5x105 CFU per mouse). bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
1014 B, C. Fungal load analyses of spleens (B) and livers (C) of WT, Casp-1-/- and Nlrp3-/- mice
1015 infected with live T. marneffei yeasts at 7 and 14 days post infection (dpi).
1016 D. Representative HE staining graphs of murine livers of WT, Casp-1-/- and Nlrp3-/- mice
1017 infected with live T. marneffei yeasts (n=4). Scale bar denotes 500 m. The insets
1018 indicate the magnified area of the smaller box containing granulomas, and the asterisk
1019 indicates massive fungal yeasts in the granulomas.
1020 E. Representative GMS staining graphs of murine livers of WT, Casp-1-/- and Nlrp3-/- mice
1021 infected with live T. marneffei yeasts (n=4). Scale bar denotes 50 m. The insets
1022 indicate the magnified area of the smaller box containing T. marneffei yeasts.
1023 Data information: In (A), the log-rank tests are performed when compared between WT and
1024 Nlrp3-/- mice groups, and between Nlrp3-/- and Casp-1-/- groups; the Gehan-Breslow-
1025 Wilcoxon test is performed between WT and Casp-1-/- groups. In (B and C), data are
1026 depicted as mean ± SEM of n=5 mice and are analyzed by two-way ANOVA. *p<0.05,
1027 **p<0.01, ***p<0.001.
1028
1029 Figure EV1. The viability of T. marneffei yeasts is dispensable for IL-1 response in human
1030 PBMCs
1031 A, B. Quantification of IL-1 by ELISA in the cell supernatant of human PBMCs (4x106/ml)
1032 stimulated with live, heat-killed or PFA-treated T. marneffei yeasts (0.5 MOI) and
1033 conidia (0.5MOI) (n=5) for 18 hr.
1034 C, D. Quantification of IL-1 by ELISA in the cell supernatant of human PBMCs (4x106/ml)
1035 stimulated with live, heat-killed or PFA-treated C. albicans yeasts (0.5 MOI) and
1036 pseudohyphae (0.5MOI) (n=5) for 18 hr. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
1037 Data information: In (A-D), data are depicted as mean ± SEM, and are analyzed by one-way
1038 ANOVA. ns =not significant, *p<0.05.
1039
1040 Figure EV2. T. marneffei yeasts elicit differential Th1 and Th17 immune responses in
1041 human CD14+ monocytes and monocytes-derived DCs.
1042 A, B. Representative flow cytometric graphs of IFN- and/or IL-17A producing CD4+ T cells
1043 (1x105/well) in human CD4+ T cells stimulated with heat-killed T. marneffei (TM) yeasts
1044 in the absence of autologous CD14+ monocytes or monocytes-derived DCs for 7 days (A)
1045 and 12 days (B).
1046 C, D. Representative flow cytometric plots of IFN- and/or IL-17A producing CD4+ T cells
1047 (1x105/well) in human CD4+ T cells stimulated with heat-killed T. marneffei (TM) yeasts
1048 in the presence of autologous CD14+ monocytes (1x105/well) for 7 days (C) and 12 days
1049 (D).
1050 E, F. Representative flow cytometric plots of IFN- and/or IL-17A producing CD4+ T cells in
1051 human CD4+ T cells (1x105/well) stimulated with heat-killed T. marneffei (TM) yeasts in
1052 the presence of autologous monocytes-derived DCs (0.2x105/well) for 7 days (E) and 12
1053 days (F).
1054 G, H. Flow cytometric analyses of T-bet (G, n=5) and RORt (H, n=4) in CD4+ T cells co-
1055 cultured with TM yeasts-primed autologous monocytes for 7 days.
1056 Data information: In (G and H), data are depicted as mean ± SEM, and are analyzed by two-
1057 tail Student’s t tests. “MFI” denotes “median fluorescence intensity”. **p<0.01.
1058
1059 Figure EV3. Histopathological analysis of murine livers and spleens. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
1060 A. Representative graphs of HE staining of spleens from WT, Nlrp3-/- and Casp-1-/- mice
1061 intravenously infected T. marneffei yeasts (5x105 CFU per mouse) at 7 days and 14
1062 days post infection (dpi) (n=4). Scale bar denotes 500 m.
1063 B. Representative graphs of GMS staining of spleens from WT, Nlrp3-/- and Casp-1-/- mice
1064 intravenously infected T. marneffei yeasts (5x105 CFU per mouse) at 7 days and 14
1065 days post infection (dpi) (n=4). Scale bar denotes 50 m. Arrows indicate T. marneffei
1066 yeasts, and the insets indicate the magnified areas containing T. marneffei yeasts. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
1
2
3 Figure 1. T. marneffei yeasts, but not conidia, induce potent IL-1b response in human
4 PBMCs
5
6 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
7
8
9 Figure 2. Differential requirement for IL-1b response to T. marneffei yeasts in various
10 human immune cell types.
11
12
13
14
15
16 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
17
18
19 Figure 3. Dectin-1/syk signaling mediates IL-1b response to T. marneffei yeasts in human
20 monocytes.
21
22
23
24
25
26
27 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
28
29
30 Figure 4. T. marneffei yeasts trigger IL-1b production via the NLRP3 inflammasome.
31 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
32
33 Figure 5. T. marneffei yeasts elicit differential Th1 and Th17 immune responses in human
34 CD14+ monocytes and monocyte-derived DCs.
35 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
36
37 Figure 6. Caspase-1 inhibition attenuates Th1 and Th17 immune responses to T. marneffei
38 yeasts. bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
39
40
41 Figure 7. The NLRP3 inflammasome controls antifungal immunity in vivo
42
43
44 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
45
46
47
48
49 Figure EV1. The viability of T. marneffei yeasts is for IL-1b response in human PBMCs
50
51
52
53
54
55
56 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
57
58
59 Figure EV2. T. marneffei yeasts elicit differential Th1 and Th17 immune responses in
60 human CD14+ monocytes and monocytes-derived DCs.
61
62
63
64 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
65
66
67 Figure EV3. Histopathological analysis of murine spleens after fungal infection
68
69
70
71
72
73
74
75 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.253518; this version posted August 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
76 Graphical abstract
77